These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37536016)

  • 21. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure.
    Liu K; Song B; Palacios IF; Inglessis-Azuaje I; Deng W; McMullin D; Wang X; Lo EH; Xu Y; Buonanno FS; Ning M
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2745-2752. PubMed ID: 33303111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
    Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
    J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ischemic stroke associated with patent foramen ovale: hospital database analysis].
    Belopasova AV; Kulesh AA; Mekhryakov SA; Chazov SA; Syromyatnikova LI; Chechetkin AO; Karshieva AR; Kadykov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3. Vyp. 2):13-19. PubMed ID: 36950816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
    Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
    J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study.
    Deng W; Yin S; McMullin D; Inglessis-Azuaje I; Elmariah S; Hung J; Lo EH; Palacios IF; Buonanno FS; Ning M
    Ann Intern Med; 2020 Jun; 172(11):717-725. PubMed ID: 32422058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patent Foramen Ovale and Risk of Recurrence in Stroke of Determined Etiology.
    Baik M; Shim CY; Gwak SY; Kim YD; Nam HS; Lee HS; Nam CM; Heo JH
    Ann Neurol; 2022 Oct; 92(4):596-606. PubMed ID: 35753038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors related to recurrence of paradoxical cerebral embolism due to patent foramen ovale.
    Fukuoka T; Dembo T; Nagoya H; Kato Y; Yasuko O; Deguchi I; Maruyama H; Horiuchi Y; Takeda H; Tanahashi N
    J Neurol; 2012 Jun; 259(6):1051-5. PubMed ID: 22057407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis.
    Katsanos AH; Spence JD; Bogiatzi C; Parissis J; Giannopoulos S; Frogoudaki A; Safouris A; Voumvourakis K; Tsivgoulis G
    Stroke; 2014 Nov; 45(11):3352-9. PubMed ID: 25293664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patent foramen ovale and stroke in intermediate-risk pulmonary embolism.
    Doyen D; Castellani M; Moceri P; Chiche O; Lazdunski R; Bertora D; Cerboni P; Chaussade C; Ferrari E
    Chest; 2014 Oct; 146(4):967-973. PubMed ID: 24874409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
    Araszkiewicz A; Sławek S; Trojnarska O; Lesiak M; Grygier M
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):159-164. PubMed ID: 29068141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
    Kent DM; Saver JL; Ruthazer R; Furlan AJ; Reisman M; Carroll JD; Smalling RW; Jüni P; Mattle HP; Meier B; Thaler DE
    Stroke; 2020 Oct; 51(10):3119-3123. PubMed ID: 32921262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of patent foramen ovale size using transcranial Doppler ultrasound in patients with ischemic stroke.
    Grisold A; Rinner W; Paul A; Gabriel H; Klickovic U; Wolzt M; Krenn M; Zimprich F; Bsteh G; Sycha T
    J Neuroimaging; 2022 Jan; 32(1):97-103. PubMed ID: 34591348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
    Sitwala P; Khalid MF; Khattak F; Bagai J; Bhogal S; Ladia V; Mukherjee D; Daggubati R; Paul TK
    Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale.
    DeSimone CV; Friedman PA; Noheria A; Patel NA; DeSimone DC; Bdeir S; Aakre CA; Vaidya VR; Slusser JP; Hodge DO; Ackerman MJ; Rabinstein AA; Asirvatham SJ
    Circulation; 2013 Sep; 128(13):1433-41. PubMed ID: 23946264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histology of Cerebral Clots in Cryptogenic Stroke Varies According to the Presence of a Patent Foramen Ovale.
    Härtl J; Berndt M; Poppert H; Liesche-Starnecker F; Steiger K; Wunderlich S; Boeckh-Behrens T; Ikenberg B
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cardiac CT throughout the full cardiac cycle in diagnosing patent foramen ovale in patients with acute stroke.
    Lee S; Kim IC; Kim YD; Nam HS; Kim SY; Choi SM; Chang HJ
    Eur Radiol; 2021 Dec; 31(12):8983-8990. PubMed ID: 34075451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.